138 related articles for article (PubMed ID: 27783703)
1. The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
Byun JM; Kim HL; Shin DY; Koh Y; Yoon SS; Seong MW; Park SS; Kim JH; Lee YG; Kim I
PLoS One; 2016; 11(10):e0163998. PubMed ID: 27783703
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Kim I; Lee KH; Kim JH; Ra EK; Yoon SS; Hong YC; Park SS; Kim CS; Park S; Kim BK
Ann Hematol; 2007 Jan; 86(1):41-8. PubMed ID: 17028897
[TBL] [Abstract][Full Text] [Related]
3. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
[TBL] [Abstract][Full Text] [Related]
5. Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.
Sugimoto K; Murata M; Onizuka M; Inamoto Y; Terakura S; Kuwatsuka Y; Oba T; Miyamura K; Kodera Y; Naoe T
Int J Hematol; 2008 Jun; 87(5):451-458. PubMed ID: 18365141
[TBL] [Abstract][Full Text] [Related]
6. The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.
Murphy NM; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King-Kallimanis B; Holdsworth R; McCluskey J; Tait BD
Biol Blood Marrow Transplant; 2012 May; 18(5):722-30. PubMed ID: 21920473
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Azarpira N; Ramzi M; Aghdaie MH; Daraie M; Geramizadeh B
Exp Clin Transplant; 2007 Dec; 5(2):693-7. PubMed ID: 18194124
[TBL] [Abstract][Full Text] [Related]
8. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
9. Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.
Rocha V; Porcher R; Fernandes JF; Filion A; Bittencourt H; Silva W; Vilela G; Zanette DL; Ferry C; Larghero J; Devergie A; Ribaud P; Skvortsova Y; Tamouza R; Gluckman E; Socie G; Zago MA
Leukemia; 2009 Mar; 23(3):545-56. PubMed ID: 19005482
[TBL] [Abstract][Full Text] [Related]
10. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
Graf Finckenstein F; Zabelina T; Dürken M; Dahlke J; Kröger N; Krüger W; Janka-Schaub G; Erttmann R; Zander AR; Kabisch H
Klin Padiatr; 2002; 214(4):206-11. PubMed ID: 12165903
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
12. Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
Pihusch M; Lohse P; Reitberger J; Hiller E; Andreesen R; Kolb HJ; Holler E; Pihusch R
Transplantation; 2004 Sep; 78(6):911-8. PubMed ID: 15385813
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
Hammrich J; Wittig S; Ernst T; Gruhn B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
[TBL] [Abstract][Full Text] [Related]
14. The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis.
Soydan E; Topcuoglu P; Dalva K; Arat M
Bone Marrow Transplant; 2008 Sep; 42(6):429-30. PubMed ID: 18587432
[No Abstract] [Full Text] [Related]
15. Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity.
Kim SY; Kim AR; Yoon SY; Cho YH; Lee MH
Ann Hematol; 2016 Feb; 95(3):483-91. PubMed ID: 26658911
[TBL] [Abstract][Full Text] [Related]
16. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
[TBL] [Abstract][Full Text] [Related]
17. MTHFR 677TT is associated with decreased number of embryos and cumulative live birth rate in patients undergoing GnRHa short protocol: a retrospective study.
Zeng H; Liu Z; Zhang L; Liu N
BMC Pregnancy Childbirth; 2022 Mar; 22(1):170. PubMed ID: 35232413
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer].
Si PR; Fang DC; Zhang H; Yang LQ; Luo YH; Liao HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):794-9. PubMed ID: 16536307
[TBL] [Abstract][Full Text] [Related]
20. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
